Pathogenesis and Morphology --;Pathogenesis of Atherosclerosis: --;Current Status --;The Extracellular Matrix of the Vessel Wall, Its Role and Modification During the Atherosclerotic Process --;Changing Views of the Morphology of Atherosclerosis --;Atherosclerosis as a Recurrent Cycle of Inflammation and Repair --;Non-Arterial Deposition of Lipids and Lipoproteins: Significance in Relation to Atherogenesis --;On the Role of Lipoprotein Antibody Immune Complexes in Atherogenesis --;Role of Different Agents Affecting Endothelial Cells in the Process of Atherosclerosis --;In Vitro Examinations --;On the Delayed Experimental Pathologic Involvement of Cerebral Arteries in Hypercholesterolemic Monkeys, Rabbits and Spontaneously Hypertensive Rats --;Enzyme-Acylalcohol-Alcohol Interactions in the Arterial Wall --;The Effect of Balloon De-Endothelialization on Arterial Enzymes and Metabolic Intermediates in Rabbits --;Epidemiology, Risk Factors --;Coronary Heart Disease Epidemiology --;Perspectives --;Obesity and Cardiovascular Disease --;Lipoproteins and Apolipoproteins in the Prediction of Coronary Artery Disease --;Prevalence of Hyperlipidaemia in British Compared with North American Men --;Low-Density Lipoprotein: Its Metabolic Determinants and Its Role in Coronary Heart Disease --;Plasma Levels of Lipoproteins and Apolipoproteins in Octo- and Nonagenarians --;Cholesteryl Ester Transfer, Lipoproteins, Hypertriglyceridemia, and Atherosclerosis --;Importance of Hypertriglyceridemia as an Independent Risk Factor: Investigations with Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia --;The Plasma Lipoproteins in Hypertriglyceridemia as Risk Factors for Atherosclerosis --;Myocardial Infarction in Women on Oral Contraceptives: Risk Factors and Mechanism --;Combined Oral Contraceptives: From Risk to Benefit? --;Bile Acids, Lipoproteins, and Atherosclerosis --;Metabolic Abnormalities in Cerebral and Peripheral Arteriosclerosis --;Elastase-Type Enzymes and Their Relation to Blood Lipids and Atherosclerosis --;DNA Polymorphisms for the Genetic Analysis of Atherosclerosis --;Lipoproteins --;Chylomicron Catabolism and Uptake by the Liver --;Lipoprotein Lipase, Synthesis and Regulation --;Structural and Clinical Aspects of the Plasma Phospholipid Subclasses --;Irregular Working Hours and Lipid Levels in Men --;Identification and Computer Modeling of Functional Domains in Plasma Apolipoproteins --;New Perspectives in Human Apolipoprotein B Metabolism --;Fish Eye Disease: Implications for the Understanding of Cardiovascular Disease and Plasma Lipoprotein Metabolism --;Diabetes --;Vascular Growth Factors and Atherogenesis in Diabetes Mellitus --;Cholesterol Biosynthesis in Diabetes Mellitus --;Effects of Diet Fat Composition on Serum Lipids and Lipoproteins in Patients with Insulin-Dependent Diabetes Mellitus --;Platelets and Thrombosis --;ß2-Glycoprotein-I (Apolipoprotein H): Possible Role in Platelet Activation and Coagulation --;Diet, Lipoproteins and Atherosclerosis --;Changes in Diet, Serum Cholesterol, and Mortality from Coronary Heart Disease in Spain --;Modified Fat Diets and Serum Lipoproteins --;Essential Fatty Acids, Marine Oils, Olive Oil and Coronary Heart Disease --;What Are the Alpha-Linolenic Acid Supplies to Be Recommended to the Normal Adult? --;Animal and Vegetable Protein Effects in Experimental Atherosclerosis --;Food Proteins and Atherosclerosis --;Cholesterol-Lowering and High-Density Lipoprotein-Raising Properties of Lecithinated Soy Proteins in Type II Hyperlipidemic Patients --;Prevention and Therapy --;From Theory to Practice: Community-Based Studies on the Prevention of Coronary Heart Disease --;Regression of Atherosclerosis in Man --;Plasma Exchange and Its Development in the Treatment of Familial Hypercholesterolemia --;The HELP System: A Novel Technique for the Extracorporeal Treatment of Familial Hypercholesterolemia --;Plasma Exchange for Severe Forms of Familial Hypercholesterolemia: 10 Years' (23 Patient Years') Experience.
SUMMARY OR ABSTRACT
Text of Note
On 29 February 1964, a group of European scientists met in Paris to discuss a subject of common interest, namely atherosclerosis research, with particular reference to international communication and collaboration.